HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alberto-Culver becoming a rarity in personal care as a large independent: stock index.

This article was originally published in The Rose Sheet

Executive Summary

ALBERTO STANDS ALONE AMIDST CONSOLIDATION FLURRY IN FIRST HALF, raising the question of how the firm will continue to grow sales and profits in the face of drug store consolidation and the ever-increasing marketing budgets from competition with greater financial resources. Alberto-Culver, already one of the last predominantly family run, large diversifieds in the industry, is looking even more rare in light of the stepped-up acquisition activity in the first half that brought Redmond Products under the Bristol-Myers Squibb umbrella and Freeman Cosmetic into the arms of Dial.
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS005591

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel